Real-world versus trial patients with transthyretin amyloid cardiomyopathy

Eur J Heart Fail. 2019 Nov;21(11):1479-1481. doi: 10.1002/ejhf.1563. Epub 2019 Jul 24.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyloid Neuropathies, Familial / drug therapy*
  • Amyloid Neuropathies, Familial / genetics
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Benzoxazoles / therapeutic use*
  • Cardiomyopathies / drug therapy*
  • Cardiovascular Agents / therapeutic use
  • Clinical Trials as Topic
  • Diuretics / therapeutic use
  • Female
  • Humans
  • Male
  • Rare Diseases

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzoxazoles
  • Cardiovascular Agents
  • Diuretics
  • tafamidis

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related